The purpose of this study is to examine cigarette smokers' use of electronic cigarettes (e-cigarettes), and how use of e-cigarettes affects short term smoking behavior.
Study initiation will commence after the first telephone contact (phone pre-screen), at the baseline visit. Additional lab visits will occur at days 8, 15, and 22 (visits 2-4). At the first study visit, 2/3rds of the participants will be randomly assigned to sample e-cigarettes and 1/3rd will not. Participants in the e-cigarette group will be provided with sufficient product to sample and use as they wish, but with minimal instruction on purpose and level of use (non-use is an outcome). Smokers in the control group will smoke their own brand of cigarettes, as they wish, for the duration of the sampling period. All participants will engage in ecological momentary assessments, which will be completed 3 times daily for 3 weeks. In-person follow-up assessments will be conducted at 1, 2, and 3 months after the final lab visit (Day 22). Overall, each participant will be contacted 8 times: at the phone pre-screening, the 4 lab visits, and 3 follow-up visits.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
68
Medical University of South Carolina
Charleston, South Carolina, United States
Uptake of Electronic Nicotine Delivery Systems (ENDS)
% of participants by group used e-cigarettes in week 16
Time frame: study week 16
Independent Purchase of an ENDs Product
% of participants by group who purchased an ENDs product on their own during the study
Time frame: study enrollment to study week 16
% Quit Attempts
% of participants who made any quit attempt during study
Time frame: study enrollment to study week 16
Point Prevalence Abstinence
% of participants with CO-verified cigarette abstinence at study week 16
Time frame: week 16
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.